Oppenheimer Adjusts Amrize Price Target to $52 From $55
Oppenheimer has lowered its price target for Amrize to $52 from $55 while maintaining an Outperform rating.
Stocks · News reference
Amrize is rolling out a 'Made in Canada' label across its domestic cement manufacturing network to emphasize local production and quality.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Oppenheimer has lowered its price target for Amrize to $52 from $55 while maintaining an Outperform rating.
DA Davidson has updated its outlook on Amrize, maintaining a Neutral rating while increasing the price target from $40 to $43.
Wells Fargo has adjusted its price target for Amrize to $39 from $40, while maintaining an Equal-Weight rating.
Berenberg Bank has lowered its price target for Amrize Ltd to $48 from $64 while maintaining a 'Buy' rating on the stock.